Concepedia

Katrin Aslan

KA

5

Publications

437

Citations

5

H-Index

2020

Active since

Affiliations

Immatics Biotechnologies (Germany)(Current)

National Center for Tumor Diseases

Universität Hamburg

University Medical Center Hamburg-Eppendorf

The University of Texas MD Anderson Cancer Center

Katrin Aslan is an author at Immatics Biotechnologies (Germany).

Publications per year

2020–2025

5

Publications

5

Tryptophan metabolism drives dynamic immunosuppressive myeloid states in IDH-mutant gliomas

Mirco Friedrich, Roman Sankowski, Lukas Bunse et al. · Nature Cancer · 2021 · 216 citations · Full text

Heterogeneity of response to immune checkpoint blockade in hypermutated experimental gliomas

Katrin Aslan, Verena Turco, Jens Blobner et al. · Nature Communications · 2020 · 160 citations · Full text

Autologous T cell therapy for PRAME+ advanced solid tumors in HLA-A*02+ patients: a phase 1 trial

Martin Wermke, Dejka M Araurjo, Manik Chatterjee et al. · Nature Medicine · 2025 · 25 citations · Full text

First-in-human dose escalation trial to evaluate the clinical safety and efficacy of an anti-MAGEA1 autologous TCR-transgenic T cell therapy in relapsed and refractory solid tumors

Martin Wermke, Tobias A.W. Holderried, Jason J. Luke et al. · Journal for ImmunoTherapy of Cancer · 2024 · 23 citations · Full text

Feasibility and Safety of Personalized, Multi-Target, Adoptive Cell Therapy (IMA101): First-in-Human Clinical Trial in Patients with Advanced Metastatic Cancer

Apostolia M. Tsimberidou, Kerstin Guenther, Börje S. Andersson et al. · Cancer Immunology Research · 2023 · 13 citations · Full text

Rows per page

1–5 of 5